A grant of £47,500 has been awarded to Yorkshire Cancer Research which will enable the University of Bradford’s Institute of Cancer Therapeutics to carry out research into pioneering cancer therapies.
The University’s Institute of Cancer Therapeutics (ICT) was able to purchase new cutting-edge equipment following the success of the Bradford Crocus Cancer Appeal, a local charitable initiative between the University, Yorkshire Cancer Research, The Sovereign Health Care Charitable Trust and the Telegraph and Argus.
Our grant will fund a research technician dedicated to operating the ICT’s new proteomics mass spectrometer.
The technician will play a vital role in discovering new cancer treatments, using the machine to identify tiny amounts of proteins founds in cancer cells. Researchers can then determine whether these proteins can be used as biomarkers for the early detection of cancer, targets for new therapies, or indicators of a patient’s likely response to current treatment.
The donation was celebrated during a visit by former Lord Mayor of London and current Assistant Grand Master of the United Grand Lodge of England, Sir David Wootton. During his visit he met with key figures involved in the project, including Richard Morgan, Director of the Institute of Cancer Therapeutics.
Professor Morgan said: “This generous donation will boost the opportunities for the discovery and development of new cancer medicines at the Institute of Cancer Therapeutics. The mass spectrometer is already helping our scientists to understand the roles that particular proteins play in the development and spread of cancer, and this additional funding will ensure our capability continues to grow.
“Their generosity has ensured that scientists at the University are now in an even better position to conduct world-leading research in the area of proteomics and use that new knowledge to help develop new anti-cancer medicines.”